Alpha2 adrenergic agonists for attention deficit hyperactivity disorder (ADHD)
Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group
Published Online: 15 AUG 2012
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Venables M, Ntzani E, Hsia Y, Gillies D. Alpha2 adrenergic agonists for attention deficit hyperactivity disorder (ADHD) (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 8. Art. No.: CD010016. DOI: 10.1002/14651858.CD010016.
- Publication Status: New
- Published Online: 15 AUG 2012
This is the protocol for a review and there is no abstract. The objectives are as follows:
In people of all ages, to assess the efficacy and safety of alpha2 agonists, alone or as an adjunct therapy, in treating core symptoms of ADHD or hyperkinetic disorder, associated comorbid symptoms and side effects.